{"id":"https://openalex.org/W4362425348","doi":"https://doi.org/10.1158/1078-0432.22439434.v1","title":"Supplementary Tables S1-S2 from Gene Expression Profile and Angiogenic Markers Correlate with Response to Neoadjuvant Bevacizumab Followed by Bevacizumab plus Chemotherapy in Breast Cancer","display_name":"Supplementary Tables S1-S2 from Gene Expression Profile and Angiogenic Markers Correlate with Response to Neoadjuvant Bevacizumab Followed by Bevacizumab plus Chemotherapy in Breast Cancer","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4362425348","doi":"https://doi.org/10.1158/1078-0432.22439434.v1"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22439434.v1","doi":"https://doi.org/10.1158/1078-0432.22439434.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22439434.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/1078-0432.22439434.v1","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103006156","display_name":"Sherry X. Yang","orcid":"https://orcid.org/0000-0002-3180-9190","observed_orcids":["https://orcid.org/0000-0002-3180-9190"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sherry X. Yang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044239219","display_name":"Seth M. Steinberg","orcid":"https://orcid.org/0000-0002-8280-551X","observed_orcids":["https://orcid.org/0000-0002-8280-551X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Seth M. Steinberg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101560871","display_name":"Dat T. Nguyen","orcid":"https://orcid.org/0009-0007-0723-3615","observed_orcids":["https://orcid.org/0009-0007-0723-3615"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dat Nguyen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022934719","display_name":"Thomas D. Wu","orcid":"https://orcid.org/0000-0003-4505-4531","observed_orcids":["https://orcid.org/0000-0003-4505-4531"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas D. Wu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074916693","display_name":"Zora D. Modrusan","orcid":"https://orcid.org/0009-0003-5647-5195","observed_orcids":["https://orcid.org/0009-0003-5647-5195"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zora Modrusan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5067203408","display_name":"Sandra M. Swain","orcid":"https://orcid.org/0000-0002-1320-3830","observed_orcids":["https://orcid.org/0000-0002-1320-3830"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sandra M. Swain","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9639000296592712,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9639000296592712,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.03500000014901161,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11885","display_name":"MRI in cancer diagnosis","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.9819999933242798},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9190000295639038},{"id":"https://openalex.org/keywords/neoadjuvant-therapy","display_name":"neoadjuvant therapy","score":0.9649999737739563},{"id":"https://openalex.org/keywords/gene-expression-profiles","display_name":"gene expression profiles","score":0.7239999771118164},{"id":"https://openalex.org/keywords/angiogenic-biomarkers","display_name":"angiogenic biomarkers","score":0.9900000095367432},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.7289999723434448},{"id":"https://openalex.org/keywords/chemotherapy","display_name":"chemotherapy","score":0.3970000147819519},{"id":"https://openalex.org/keywords/angiogenesis","display_name":"angiogenesis","score":0.5410000085830688}],"concepts":[{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.9616060256958008},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.7141331434249878},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6776371598243713},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6208140254020691},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6140620112419128},{"id":"https://openalex.org/C2778292576","wikidata":"https://www.wikidata.org/wiki/Q6991934","display_name":"Neoadjuvant therapy","level":4,"score":0.488252192735672},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.48758095502853394},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.37872451543807983},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3443564474582672}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.22439434.v1","doi":"https://doi.org/10.1158/1078-0432.22439434.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22439434.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22439434","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Tables_S1-S2_from_Gene_Expression_Profile_and_Angiogenic_Markers_Correlate_with_Response_to_Neoadjuvant_Bevacizumab_Followed_by_Bevacizumab_plus_Chemotherapy_in_Breast_Cancer/22439434","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22439434.v1","doi":"https://doi.org/10.1158/1078-0432.22439434.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22439434.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.6499999761581421,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3142026086","https://openalex.org/W2028827184","https://openalex.org/W2146312028","https://openalex.org/W2037317309","https://openalex.org/W2733092439","https://openalex.org/W2051540233","https://openalex.org/W2090201823","https://openalex.org/W2989121736","https://openalex.org/W2892677547","https://openalex.org/W2460051703"],"abstract_inverted_index":{"Supplementary":[0],"Tables":[1],"S1-S2":[2],"from":[3],"Gene":[4],"Expression":[5],"Profile":[6],"and":[7],"Angiogenic":[8],"Markers":[9],"Correlate":[10],"with":[11],"Response":[12],"to":[13],"Neoadjuvant":[14],"Bevacizumab":[15,18],"Followed":[16],"by":[17],"plus":[19],"Chemotherapy":[20],"in":[21],"Breast":[22],"Cancer":[23]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2025-10-10T00:00:00"}